About pmv pharmaceuticals inc - PMVP
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
PMVP At a Glance
PMV Pharmaceuticals, Inc.
400 Alexander Park Drive
Princeton, New Jersey 08540
| Phone | 1-609-642-6670 | Revenue | 0.00 | |
| Industry | Biotechnology | Net Income | -77,742,000.00 | |
| Sector | Health Technology | Employees | 54 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
PMVP Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 0.637 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.539 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | -0.018 |
PMVP Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -1,439,666.667 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
PMVP Liquidity
| Current Ratio | 10.094 |
| Quick Ratio | 10.094 |
| Cash Ratio | 9.894 |
PMVP Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -50.506 |
| Return on Equity | -55.373 |
| Return on Total Capital | -73.654 |
| Return on Invested Capital | -55.123 |
PMVP Capital Structure
| Total Debt to Total Equity | 0.80 |
| Total Debt to Total Capital | 0.794 |
| Total Debt to Total Assets | 0.719 |
| Long-Term Debt to Equity | 0.415 |
| Long-Term Debt to Total Capital | 0.412 |